SERIES B WARRANT FOR THE PURCHASE OF _________ SHARES OF COMMON STOCK, $0.001 PAR VALUEWarrant Agreement • October 13th, 2006 • China Aoxing Pharmaceutical Company, Inc. • Pharmaceutical preparations • New York
62- 2 TALLEY KING MANAGEMENTManagement Agreement • December 27th, 1999 • Central American Equities Inc • Hotels & motels
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 25th, 2015 • Aoxing Pharmaceutical Company, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 24, 2015, between Aoxing Pharmaceutical Company, Inc., a Florida corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON STOCK PURCHASE WARRANT AOXING PHARMACEUTICAL COMPANY, INC.Common Stock Purchase Warrant • October 1st, 2015 • Aoxing Pharmaceutical Company, Inc. • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after March 30, 2016 (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Aoxing Pharmaceutical Company, Inc., a Florida corporation (the “Company”), up to _________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 12th, 2009 • China Aoxing Pharmaceutical Company, Inc. • Pharmaceutical preparations • New Jersey
This Securities Purchase Agreement (this “Agreement”) is dated as of July 31, 2009, between China Aoxing Pharmaceutical Company, Inc., a Florida corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
EXHIBIT 10: MANAGEMENT AGREEMENTManagement Agreement • October 20th, 1999 • Central American Equities Inc • Hotels & motels
RECITALSPut and Call Option Agreement • March 15th, 2006 • Central American Equities Inc • Hotels & motels • New York
No. ___] [US $_____] CHINA AOXING PHARMACEUTICAL COMPANY, INC. 10% CONVERTIBLE DEBENTURE THIS DEBENTURE ("Debenture") is issued by CHINA AOXING PHARMACEUTICAL COMPANY, INC., a Florida corporation (the "Company"), and is designated as its 10%...Convertible Debenture • November 13th, 2006 • China Aoxing Pharmaceutical Company, Inc. • Pharmaceutical preparations • New York
Exh 10-d Midterm RMB Loan Contract Number 10, Year 2003 Debtor: Hebei Aoxing Pharmaceutical Group Co. Ltd. ----------------------------------------- License number: 1301841000054 ------------- Authorized representative: Yue, Zheng Jiang...Loan Agreement • April 24th, 2006 • Central American Equities Inc • Hotels & motels
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 20th, 2010 • China Aoxing Pharmaceutical Company, Inc. • Pharmaceutical preparations • Florida
This EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of January 13, 2010 by and between China Aoxing Pharmaceutical Company, Inc, a company incorporated under the laws of the Florida (the “Company”), and Mr. Hui Shao , an individual (the “Executive”) and effective on the Effective Date (as hereinafter defined). The term “Company” as used herein with respect to all obligations of the Executive hereunder shall be deemed to include the Company and all of its direct or indirect parent companies, subsidiaries, affiliates, or subsidiaries or affiliates of its parent companies (collectively, the “Company”).
RECITALSSubsidiary Purchase Agreement • March 15th, 2006 • Central American Equities Inc • Hotels & motels • New York
JOINT STRATEGIC ALLIANCE AND SECURITIES PURCHASE AGREEMENTJoint Strategic Alliance and Securities Purchase Agreement • April 21st, 2008 • China Aoxing Pharmaceutical Company, Inc. • Pharmaceutical preparations • New York
THIS JOINT STRATEGIC ALLIANCE AND SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of April 15, 2008, is made and entered into by and between American Oriental Bioengineering Inc., a corporation organized under the laws of the State of Nevada (“AOBO” or the “Investor”), and China Aoxing Pharmaceutical Company, Inc., a corporation organized under the laws of the State of Florida (“CAXG” or the “Issuer”).
1 EXHIBIT 10: OPTIONS AGREEMENTS OPTION AGREEMENT WITH ELSA MONGE This Agreement is entered into this 9th day of April 1998 between Central American Equities, a Florida Corporation ("Company") and Elsa Monge (Purchaser). Option. Company hereby grants...Option Agreement • December 27th, 1999 • Central American Equities Inc • Hotels & motels
43- 2 None of the outstanding shares of ISSUER are subject to any stock restriction agreements. All of the shareholders of ISSUER have valid title to such shares and acquired their shares in a lawful transaction and in accordance with the laws of Florida.Agreement for the Exchange of Common Stock • December 27th, 1999 • Central American Equities Inc • Hotels & motels
ContractConvertible Term Note • August 20th, 2008 • China Aoxing Pharmaceutical Company, Inc. • Pharmaceutical preparations • New York
THIS NOTE AND THE COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THIS NOTE AND THE COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS NOTE UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR (B) AN EXEMPTION FROM SUCH REGISTRATION REQUIREMENTS.
ACQUISITION AGREEMENTAcquisition Agreement • March 13th, 2008 • China Aoxing Pharmaceutical Company, Inc. • Pharmaceutical preparations • Florida
THIS ACQUISITION AGREEMENT (this "Agreement") is dated as of March 11, 2008, by and among China Aoxing Pharmaceutical Company Inc, a Florida Corporation (the "Purchasers", "CAXG" or the "Company"), Shijiazhuang Lerentang Pharmaceutical Company Limited, a Chinese corporation ("LRT" or the "Acquiree").
Debt Conversion AgreementDebt Conversion Agreement • June 28th, 2011 • Aoxing Pharmaceutical Company, Inc. • Pharmaceutical preparations • Florida
This Debt Conversion Agreement (this “Agreement”), dated as of June 26, 2011, is being entered into by and between Aoxing Pharmaceuticals, Inc., a Florida corporation (the “Company”), and holders of the Notes (as defined below) of the Company as set forth in Schedule A hereto (collectively, the “Holders”).
奥星制药公司CFO聘用合同 Aoxing Pharmaceutical Company, Inc. CFO employment contractCfo Employment Contract • December 29th, 2014 • Aoxing Pharmaceutical Company, Inc. • Pharmaceutical preparations
Exh. 10-c STOCK PURCHASE AGREEMENT AGREEMENT made this 14th day of September, 2006 between CHINA AOXING PHARMACEUTICAL COMPANY, INC., a Florida corporation with offices c/o American Union Securities, Inc., 100 Wall Street, 15th Floor, New York, NY...Stock Purchase Agreement • October 13th, 2006 • China Aoxing Pharmaceutical Company, Inc. • Pharmaceutical preparations
EMPLOYMENT AGREEMENT (English version for reference only) February 1, 2011Employment Agreement • February 7th, 2011 • Aoxing Pharmaceutical Company, Inc. • Pharmaceutical preparations
This Agreement is made as of the 1st day of February, 2011 between Aoxing Pharmaceutical Company, Inc., with offices at 15 Exchange Place, Suite 500, Jersey City, NJ 07302 (the "Company"), and Bob Yunjun Ai, an individual residing in the State of New Jersey (the "Employee").
EXHIBIT 10: AGREEMENT WITH GEORGE SOLANO CENTRAL AMERICAN EQUITIES, INC. A FLORIDA CORPORATION =========================================================== =====================Agreement With George Solano • October 20th, 1999 • Central American Equities Inc • Hotels & motels
EXHIBIT 10: OTHER OPTION AGREEMENTS MARIO OSCAR FENNELL ARAYA This agreement is entered into this 29th day of April 1998 between Central American Equities, A Florida Corporation ("Company") and Mario Oscar Fennell Araya (Purchaser). Option. Company...Option Agreement • October 20th, 1999 • Central American Equities Inc • Hotels & motels
CFO聘用合同 Aoxing Pharmaceutical Company, Inc. CFO Employment Contract Party A: Aoxing Pharmaceutical Company, Inc. Party B: Zheng Chen Party A and Party B agreed to reach the following terms and conditions after friendly negotiation.Cfo Employment Contract • February 1st, 2016 • Aoxing Pharmaceutical Company, Inc. • Pharmaceutical preparations • New Jersey
by and amongMerger Agreement • March 15th, 2006 • Central American Equities Inc • Hotels & motels • New York
Exh 10-e Midterm RMB Loan Contract Number 11, Year 2003Loan Agreement • April 24th, 2006 • Central American Equities Inc • Hotels & motels
Agreement to Purchase AXN SharesAgreement to Purchase Axn Shares • October 7th, 2014 • Aoxing Pharmaceutical Company, Inc. • Pharmaceutical preparations
This agreement will become effective on the date that this transaction is approved by the NYSE MKT. Within one week after approval, Party B will pay the purchase price to Party A, and Party A will deliver to Party B a certificate for the Shares.
65- 2 Amendments/Modifications. Any provision in this Agreement may be amended and/or modified only in writing signed by the party to be charged.Option Agreement • December 27th, 1999 • Central American Equities Inc • Hotels & motels
Agreement Between China Aoxing Pharmaceutical Company and Mr Zhenjiang YuePurchase Agreement • September 6th, 2007 • China Aoxing Pharmaceutical Company, Inc. • Pharmaceutical preparations
On September 4, 2007, China Aoxing Pharmaceutical Company (“China Aoxing”) and Mr. Zhenjiang Yue reached the following agreement with regard to the purchase of 35% interest in Hebei Aoxing Pharmaceutical Group Co. Ltd. (“Hebei Aoxing”), the main operating subsidiary of China Aoxing, from its Chairman and the Chief Executive Officer, Mr. Zhenjiang Yue.
